Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique最新文献

{"title":"Validation of the French version of the Sexual Motivation Scale (SexMS-Fr).","authors":"Komlan Gnimavo Hegbe, Aurélien Ribadier, Servane Barrault","doi":"10.1016/j.encep.2026.06.009","DOIUrl":"https://doi.org/10.1016/j.encep.2026.06.009","url":null,"abstract":"<p><strong>Objectives: </strong>Sexual motivations can be defined as the internal and external forces leading to an individual's engagement in sexual behaviors. To understand these motivations it may be useful to develop reliable assessment tools. The first aim of the present research was to develop and validate a French version of the Sexual Motivation Scale (SexMS-Fr) by testing its psychometric qualities. The second aim was to identify motivational specific factors among participants with and without sexual addiction.</p><p><strong>Methods: </strong>One hundred seventy-four voluntary participants completed a sociodemographic questionnaire, the SexMS-Fr (sexual motivations) and the SAST-Fr (sexual addiction). We tested the psychometric properties and reliability of the SexMS-Fr through exploratory factor analysis. We also performed construct validity analysis on the one hand and comparison analysis for participants with and without sexual addiction on the other.</p><p><strong>Results: </strong>Our results indicated a six-factor structure of the SexMS-Fr subscales explaining 61.9% of the total variance and good to excellent internal consistency. We also found that the psychometric properties of the French version of the SexMS were comparable to those of the original English version, with a six-factor structure. Finally, the intrinsic motivation, identified regulation, and amotivation dimensions were significantly different between participants with or without addictive sexual behaviors.</p><p><strong>Conclusion: </strong>The SexMS-Fr is a reliable, valid scale for assessing sexual motivation and detecting differential associations between sexual motivation and sexual addiction.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149009490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Management of residual excessive daytime sleepiness in depression: An AFPBN consensus using the nominal group technique.","authors":"Jean-Arthur Micoulaud-Franchi, Julia Maruani, Isabelle Lambert, Laure Peter-Derex, Antoine Yrondi, Sébastien Baillieul, Wojciech Trzepizur, Luc Masset, Sibylle Mauries, Clélia Quiles, Pierre-Alexis Geoffroy","doi":"10.1016/j.encep.2026.08.002","DOIUrl":"https://doi.org/10.1016/j.encep.2026.08.002","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Excessive daytime sleepiness and broader hypersomnolence symptoms may persist despite improvement of core depressive symptoms, yet no specific clinical framework currently guides their assessment and management in mood disorders. This work aimed to establish a national expert consensus on the definition, assessment, management and follow-up of residual excessive daytime sleepiness associated with depression (rEDS-dep).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A nominal group consensus process was conducted from September 2025 to April 2026. A Steering Committee comprised eleven French experts with clinical and scientific expertise in psychiatry, neurology, pulmonology and sleep medicine. After a comprehensive literature review, the experts anonymously generated statements covering four domains: definition, clinical assessment, management and follow-up. Statements were discussed during two collective meetings, then rated anonymously on a 9-point Likert scale. Strong consensus was defined as more than 75% of scores≥7 combined with a median score≥8; good consensus was defined when only one of these criteria was met. Statements not reaching good/strong consensus or requiring clarification were revised and submitted to a second round of voting.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The initial nominal group phase produced 70 statements. After two voting rounds, 48 statements were retained: 35 (73%) reached strong consensus, one (2%) reached good consensus and 12 (25%) did not reach consensus. Experts agreed on a pragmatic definition of rEDS-dep as a specific clinical syndrome characterized by a persistent alteration of arousal, associated with a significant distress and/or disability (functional impairment), and increased risk of depressive relapse and/or disability. This diagnosis is made after excluding other better possible explanations: persisting depressive symptoms, psychiatric, other medical cause, iatrogenic, or psychotropic substance-related causes, or causes related to another sleep disorder. Consensus supported a multidimensional definition including excessive daytime sleepiness, daytime drowsiness, prolonged sleep duration, involuntary naps, and/or sleep inertia, persisting daily or almost daily for more than three months despite adequate treatment and improvement of core depressive symptoms. Assessment should integrate symptom frequency and severity, related distress and/or disability, sleep and circadian behaviours, comorbidities, psychotropic exposure, sleepiness related accident risk, sleep diary, actigraphy when indicated, and self-report measures such as the Hypersomnia Severity Index (HSI) questionnaire. First-line management should prioritize reassessment of psychotropic treatments, reduction of sedative co-medications when appropriate, patient information on sleep and circadian behaviours and lifestyle habits, specific circadian interventions including morning light therapy, and occupational adaptations. Wake-prom","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149009485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Digital psychiatric biomarkers beyond the walls: A Science and Technology Studies view.","authors":"Vincent P Martin, Elodie Gratreau, Stéphane Mouchabac, Gemma Serrano, Jean-Arthur Micoulaud-Franchi","doi":"10.1016/j.encep.2026.07.004","DOIUrl":"https://doi.org/10.1016/j.encep.2026.07.004","url":null,"abstract":"<p><strong>Background: </strong>As traditional biomarkers have failed to deliver on promises of personalized diagnosis and treatment in psychiatry, digital biomarkers offer continuous and ecologically valid monitoring. By capturing symptoms directly within patients' everyday environments, they support a systemic approach to psychiatry. However, this ecological dimension challenges conventional validation criteria and requires in situ validation beyond research laboratories.</p><p><strong>Objectives: </strong>This study has two aims: first, to identify and compare standardization documents that could support validation standards for digital biomarkers in psychiatry; second, to situate these documents within a circulation framework between laboratories and the real world, inspired by the sociology of innovation, in order to analyze their dynamics. Methods Standardization documents relating to the validation of digital biomarkers and smartphone applications in psychiatry were identified through expert selection. Their main dimensions were extracted and mapped onto a framework linking laboratories and the \"wider world\". This process was conducted by an interdisciplinary consortium combining computer science, psychiatry, and Science and Technology Studies (STS).</p><p><strong>Results: </strong>Four heterogeneous standardization documents were identified. Mapping their components within the circulation framework enabled comparison of the documents and of the design constraints they implement.</p><p><strong>Discussion: </strong>The findings suggest that these standardization documents are not yet stabilized. Rather than fixed standards, they function as tools for negotiation between epistemic communities and actors with unequal power relations, within academic infrastructures that maintain biases. This highlights the need for a socio-technical democracy in mental health.</p><p><strong>Conclusion: </strong>STS provides valuable tools for understanding the dynamics of standardization and the plurality of actors involved in validating digital biomarkers in psychiatry.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149009468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are online poker players motivated to expend effort for monetary rewards?","authors":"Julie Giustiniani, Magali Nicolier, Florine Maylié, Lionel Pazart, Emmanuel Haffen, Damien Gabriel","doi":"10.1016/j.encep.2026.06.010","DOIUrl":"https://doi.org/10.1016/j.encep.2026.06.010","url":null,"abstract":"<p><p>Motivation in poker players has typically been studied through monetary incentives rather than physical effort expenditure. In this exploratory study we hypothesized that poker players' protected decision-making performance might be associated with a heightened willingness to exert effort for monetary rewards. We recruited 69 participants: 49 online poker players, 20 classifieds as low-risk gamblers (LR) and 29 as problematic gamblers (PG; one participant was excluded due to a psychiatric comorbidity), and 20 non-gamblers (NG). Participants completed self-report personality questionnaires (BIS-10, BFI, BIS/BAS) and two behavioral tasks: the Iowa Gambling Task (IGT), assessing decision-making under uncertainty, and the Effort Expenditure for Rewards Task (EEfRT) measuring willingness to invest physical effort for monetary rewards. IGT performance was similar across all groups, supporting the hypothesis of protected decision-making in poker players. Contrary to our initial prediction, both gambling groups selected effortful options less frequently than NG participants in the EEfRT. Moreover, PG participants scored lower on BFI agreeableness and openness. These findings indicate that, while decision-making under uncertainty appears intact, poker players are less willing to invest physical effort for rewards and display a less agreeable and aggressive personality profile, suggesting that preserved IGT performance is not underpinned by greater effort expenditure.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149009492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"[Nociplastic pain and the brain: Toward an integrative reappraisal of chronic pain in psychiatry].","authors":"Hugues Magne","doi":"10.1016/j.encep.2026.06.008","DOIUrl":"https://doi.org/10.1016/j.encep.2026.06.008","url":null,"abstract":"","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Drug-induced stuttering following serotonin reuptake inhibitors treatment: About two case reports and literature review.","authors":"Frank Lach, Guillaume Meyer, Anaïs Suplon, Hervé Javelot","doi":"10.1016/j.encep.2026.06.004","DOIUrl":"https://doi.org/10.1016/j.encep.2026.06.004","url":null,"abstract":"","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Demoralization in patients with cancer: Validation of the French version of the demoralization scale I (DS-I).","authors":"Marianne Cochet, Rémy Bation, David Kissane, Julie Haesebaert, Guillaume Economos","doi":"10.1016/j.encep.2026.06.005","DOIUrl":"https://doi.org/10.1016/j.encep.2026.06.005","url":null,"abstract":"<p><strong>Background: </strong>This study focused on the phenomenon of demoralization, an experience of emotional distress frequently observed in patients with severe chronic illnesses, particularly those with cancer.</p><p><strong>Objectives: </strong>The aims of this study were to adapt a standard instrument for assessing demoralization - the Demoralization Scale I (DS-I) - into French and to examine its content validity.</p><p><strong>Methods: </strong>First, we developed a French version of the Demoralization Scale I through forward and backward translation procedures. Second, we conducted a qualitative thematic study based on cognitive interviews with 12 French patients with cancer to assess the content validity of our French translation of the Demoralization Scale I.</p><p><strong>Results: </strong>Our French version of the Demoralization Scale I seemed satisfactory in light of the COSMIN methodological recommendations for the translation of instruments. Our version of the Demoralization Scale I also demonstrated an acceptable content validity through the cognitive interviews conducted with patients.</p><p><strong>Conclusions: </strong>Our findings suggest that further validation of the French version of the Demoralization Scale I should be continued in future studies. This would ensure rapid diagnosis of demoralization in affected patients and the initiation of therapeutic interventions.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A script concordance test to implement 2024 HAS ADHD guidelines in primary care.","authors":"Laurie Sürig, Erica Fongaro, Hala Kerbage, Jean Paul Blanc, Virginie Desgrez, Sophie Soudée Mayer, Diane Purper-Ouakil, Thiébaut-Noël Willig","doi":"10.1016/j.encep.2026.06.003","DOIUrl":"https://doi.org/10.1016/j.encep.2026.06.003","url":null,"abstract":"<p><strong>Background: </strong>The 2024 French Haute Autorité de santé (HAS) guidelines introduced the concept of an \"ADHD-specialized physician\" calling for competency-based models to support broader, evidence-based ADHD care for children and adolescents. However, no standardized assessment currently exists to evaluate the clinical reasoning required for this role.</p><p><strong>Objective: </strong>This study describes the development and initial validation of a Script Concordance Test (SCT) designed to assess clinical reasoning in ADHD management, with potential applications as both a pedagogical and certification tool.</p><p><strong>Methods: </strong>Following international standards for SCT design, the test was constructed using a structured blueprint aligned with HAS 2024 guidelines. A panel of 25 national experts completed the full version (72 items); after reviewing the items and excluding those with low consensus, 43 items were retained. Inter-rater agreement was analyzed using Kendall's coefficient of concordance (W=0.67). Qualitative validation was achieved through iterative expert consensus ensuring clarity, relevance, and representativeness.</p><p><strong>Results: </strong>The expert panel demonstrated substantial concordance (Kendall's W=0.67) consistent with previous SCT validation studies in psychiatry and pediatrics. Qualitative reviews confirmed the clarity, representativeness, and clinical relevance of the retained items.</p><p><strong>Conclusions: </strong>This SCT provides a valid and adaptable method to assess higher-order clinical reasoning in ADHD care. By operationalizing the competencies implied in the HAS 2024 guidelines, it may support the emerging role of the \"ADHD-specialized physician\" and contribute to competency-based certification models similar to those used in other regulated medical practices.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biofeedback for Attention Deficit and Hyperactivity Disorder in children: A pilot study of a multimodal approach of respiratory biofeedback to improve functional impact.","authors":"Camilla M Barbini, Diane Merino, Valeria Manera, Roxane Fabre, André Quaderi, Florence Askenazy, Susanne Thümmler","doi":"10.1016/j.encep.2026.06.007","DOIUrl":"https://doi.org/10.1016/j.encep.2026.06.007","url":null,"abstract":"<p><p>Defined as a complex syndrome combining attentional and behavioral difficulties, Attention Deficit Hyperactivity Disorder (ADHD) is a widespread condition affecting approximately 5.3% of children worldwide. Treatments mainly include psychotherapy and amphetamine derivative-based pharmacotherapy. Respiratory biofeedback may represent an additional, promising non-pharmacological approach for ADHD, in addition to neurofeedback, biofeedback's actual main application protocol based on cerebral activity. However, to date, there are few studies regarding other physiological rhythms, such as breathing. This study explored the potential effects of a therapeutic intervention based on respiratory, haptic and visual biofeedback, aiming to reduce the intensity of attentional dysfunction symptoms in children with ADHD aged 8 to 11 years. In this crossover protocol, we set two intervention groups: an immediate group and a delayed group. The intervention phase consisted of five weekly respiratory biofeedback sessions focused on attention processes, along with the monitoring of symptomatic manifestations using validated psychometric tools. Among the 17 participants, the results showed a significant overall decrease in ADHD evaluation scale scores both immediately after the intervention and at the 30-day follow-up, indicating short-term benefits from the sessions. However, these benefits were attenuated in the medium term, possibly due to the limited number of biofeedback sessions. In conclusion, respiratory biofeedback was well accepted, and few sessions decreased in the short term symptomatic manifestations and functional impacts related to ADHD. However, treatment effects, permanence and acceptability need to be assessed in larger and longer cohort studies. Thus, a multimodal biofeedback approach based on respiratory feedback is an innovative preliminary but promising emerging perspective for children presenting ADHD.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148867850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"List of essential medicines for French psychiatry.","authors":"Hervé Javelot, Amélie Rousseau-Voisin, Mathilde Le Maout, Guillaume Sujol, Stéphane Honore, Davy Beauger, David Gourion, Antoine Yrondi","doi":"10.1016/j.encep.2026.04.011","DOIUrl":"https://doi.org/10.1016/j.encep.2026.04.011","url":null,"abstract":"<p><p>In the context of medication shortages, the creation of a list of essential medications (EML) is becoming necessary in France, as it is in other industrialized countries newly affected by this issue. This approach differs from the World Health Organization's EML and is thought of as an extension of the definition of medications (and therapeutic classes) of major therapeutic importance as outlined in the public health code. The principle behind this list is to maintain a high standard of care. The first EML for French psychiatry was formalized by the French Association of Biological Psychiatry and Neuropsychopharmacology (AFPBN) in June 2023. It was initially compiled by a steering committee of five mental health practioners and proposed to a panel of 31 experts who were asked to rate their degree of approval for each medication (Delphi method) along with the level of criticality in the event of a shortage. Based on 163 medications, the AFPBN selected 98, after validation by its expert group. (June 2023). The Directorate General of Health later removed 18 medications from this list, including molecules with no medical benefit, mainly substances under compassionate use authorization, or those with an insufficient, low, or moderate medical benefit. This first EML for French psychiatry can obviously be improved but is proposed as a working basis for future modifications.</p>","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":" ","pages":""},"PeriodicalIF":1.3,"publicationDate":"2026-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148857877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}